Skip to main content
ABL Bio Inc. logo

ABL Bio Inc. — Investor Relations & Filings

Ticker · 298380 ISIN · KR7298380007 LEI · 9884007BRC71Y64NK235 KO Professional, scientific and technical activities
Open in API
Filings indexed 369 across all filing types
Latest filing 2019-03-21 Board/Management Inform…
Country KR South Korea
Listing KO 298380

About ABL Bio Inc.

https://www.ablbio.com

ABL Bio Inc. is a clinical-stage biotechnology company specializing in the development of bispecific antibody therapeutics for immuno-oncology and neurodegenerative diseases. The company leverages several proprietary platforms. For central nervous system disorders, its 'Grabody-B' technology is a blood-brain barrier (BBB) penetrating shuttle designed to enhance drug delivery to the brain. In immuno-oncology, ABL Bio develops 4-1BB based bispecific antibodies aimed at minimizing toxicity and overcoming resistance to existing immunotherapies. The company is also advancing a pipeline of antibody-drug conjugates (ADCs) with an improved therapeutic index for conditions such as rare blood cancers. ABL Bio actively progresses its therapeutic candidates through clinical development.

Recent filings

Filing Released Lang Actions
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). This document specifically details changes to the company's board of directors, which falls under the 'Board/Management Information' category.
2019-03-21 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). This document specifically details changes to the company's board of directors, which falls under the 'Board/Management Information' category.
2019-03-21 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment or dismissal of an outside director (사외이사의 선임ㆍ해임). This falls under the category of board and management changes, which is classified as MANG.
2019-03-21 Korean
감사보고서제출
Audit Report / Information Classification · 98% confidence The document is a formal announcement titled '감사보고서 제출' (Submission of Audit Report) filed by ABL Bio. It provides the audit opinion, key financial data, and details regarding the auditor (Samil PwC). According to the 'Menu vs Meal' rule, this is an announcement of the audit report submission rather than the full audit report document itself. Therefore, it is classified as a Report Publication Announcement (RPA). FY 2018
2019-03-13 Korean
주주총회소집공고
AGM Information Classification · 100% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for ABL Bio. It contains the agenda for the meeting, including the approval of financial statements, election of directors, and other corporate governance matters. It also includes detailed management reports (business overview, pipeline status, and contracts) as part of the meeting materials. This is a standard document provided to shareholders prior to an AGM to inform them of the meeting's purpose and provide necessary background information.
2019-03-06 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for ABL Bio. It details the date, location, and specific agenda items (approval of financial statements, appointment of directors, etc.) to be voted upon. This type of document is a standard proxy solicitation and information statement provided to shareholders prior to a meeting to inform them of the agenda and request their participation/votes.
2019-03-06 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.